Publicity15 Apr 2021 13:13
Please see below article on MXC (by Alistair Strang) taken off ii website:
"MGC Pharmaceuticals Ltd
MXC is a relatively new listing on the London Stock Exchange, and offers research and medications derived from cannabis.
MGC is already listed on the Australian exchange, showing a relatively stable history for the last few years. Its website lays out global ambitions, and there's little doubt the listing in London has provoked some interest in the share price’s future.
Currently trading around 3.6p, the share price need only better 4.9p to tick a pretty major box in a tier of calculations which allows price movement to an initial 7.4p. If exceeded, our secondary longer-term calculation works out at 10.5p. Surprisingly, we not if similar logic is applied to their Australian listing, this permits a high at 21 Australian cents (12p).
At present, we cannot comfortably calculate beyond either secondary level and believe we shall have to revisit the company should such targets make an appearance.
As always, there's a risk of a downside. Currently, it looks possible weakness below 3.4p risks driving the price back to 2.6p. We cannot calculate anything below such a level and would expect a rebound, if such a number ever appears."
Upside looks sizeable.
GLA DYOR
Elcap